Free Trial
TSE:SVA

Sernova (SVA) Stock Price, News & Analysis

Sernova logo
C$0.21 +0.02 (+7.69%)
As of 03:37 PM Eastern

About Sernova Stock (TSE:SVA)

Key Stats

Today's Range
C$0.19
C$0.21
50-Day Range
C$0.15
C$0.22
52-Week Range
C$0.15
C$0.41
Volume
224,613 shs
Average Volume
141,939 shs
Market Capitalization
C$70.66 million
P/E Ratio
N/A
Dividend Yield
7.86%
Price Target
C$2.00
Consensus Rating
Buy

Company Overview

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on Type 1 diabetes and thyroid disorders.

Sernova Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

SVA MarketRank™: 

Sernova scored higher than 33% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sernova has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Sernova has received no research coverage in the past 90 days.

  • Read more about Sernova's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sernova is -2.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sernova is -2.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for SVA.
  • Dividend Leadership

    Sernova is a leading dividend payer. It pays a dividend yield of 7.86%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Sernova does not have a long track record of dividend growth.

  • Read more about Sernova's dividend.
  • Short Interest

    There is no current short interest data available for SVA.
  • Search Interest

    1 people have searched for SVA on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Sernova insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.13% of the stock of Sernova is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 0.05% of the stock of Sernova is held by institutions.

  • Read more about Sernova's insider trading history.
Receive SVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter.

SVA Stock News Headlines

Sernova Biotherapeutics Inc (SVA.TO)
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
Jobs Reports Due for Next Week
School of Visual Arts
Sernova Announces Key New Executive Appointments
See More Headlines

SVA Stock Analysis - Frequently Asked Questions

Sernova's stock was trading at C$0.23 at the beginning of the year. Since then, SVA shares have decreased by 6.7% and is now trading at C$0.21.
View the best growth stocks for 2025 here
.

Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sernova investors own include ARC Resources (ARX), Meta Platforms (META), Newron Pharmaceuticals (NWPHF), Sernova (SEOVF), AMC Entertainment (AMC), Advanced Micro Devices (AMD) and CloudMD Software & Services (DOC).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:SVA
CIK
N/A
Fax
N/A
Employees
1,959
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$2.00
High Stock Price Target
C$2.50
Low Stock Price Target
C$1.50
Potential Upside/Downside
+852.4%
Consensus Rating
Buy
Rating Score (0-4)
3.33
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-35,698,842.53
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.03 per share
Price / Cash Flow
6.15
Book Value
C($0.04) per share
Price / Book
-4.92

Miscellaneous

Free Float
N/A
Market Cap
C$70.66 million
Optionable
Not Optionable
Beta
1.35
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (TSE:SVA) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners